搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 3 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Novartis lifts guidance after first-quarter results beat expectations
CNBC· 2 日前Swiss drugmaker Novartis on Tuesday raised its full-year guidance after reporting ...
Grassroots healthcare gets a boost
China Daily· 1 日前Health authorities in China plan to increase the number of community hospitals and rural clinics, bolster the quality of ...
Is Your Relationship Suffering From ‘One-Upmanship’? A Psychologist Explains
Forbes· 3 日前One-upmanship is a prevalent phenomenon wherein people partake in subtle or overt competition to assert superiority over ...
A Psychologist Explains The ‘Acceptance Versus Change’ Paradox
Forbes· 5 日前The paradox of acceptance and change often appears contradictory. At first glance, acceptance and change seem like opposing ...
Imagine Dragons' Dan Reynolds talks new album 'Loom' — 'Heavy concepts but ...
Bastillepost· 3 日前NEW YORK (AP) — The ambiguity of Imagine Dragons' next album starts from the cover.Two ...